What Is Our Impact? – NGF 2019 Impact Report
In our 2019 Impact Report, we take a look at... Read more
AVROBIO Receives Orphan-Drug Designation from FDA for AVR‑RD‑02
AVROBIO announced that the U.S. Food and Drug Administration (FDA)... Read more
Developing Enzyme Replacement Therapy – An Insider’s Perspective
Enzyme replacement therapy (ERT) was first approved for use by... Read more
[MEDTalks Video] Managing Bone Health
Growth in Gaucher: Managing Bone Health Dr. Heather A. Lau,... Read more
[MEDTalks Video] Does the Key Biomarker of Gaucher Disease Hold the Key to Understanding?
Illuminating Lyso-Gyl 1: Does the Key Biomarker of Gaucher Disease... Read more
Clinical Trials & Gaucher Disease: Phases, Types, & What You Should Know
Medical research has always been important for furthering our understanding... Read more
Repealing the Affordable Care Act
How Repealing the ACA Could Impact the Gaucher Disease... Read more
What You Should Know About At-Home Genetic and Ancestry Testing Kits
Genetic testing, including ancestry testing, has increased in popularity in... Read more
Gaucher Disease: Enzyme Replacement Therapy, Substrate Reduction Therapy & Potential Drug Interaction Side Effects
Substrate reduction therapy (SRT) first debuted as an alternative method... Read more
Ambassador Spotlight: Lauren Edwards
What were the events leading up to your diagnosis? What... Read more
